These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients. Paniagua GL, Monroy E, Negrete E, Vaca S. Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773 [Abstract] [Full Text] [Related]
3. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro. Odds FC. Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266 [Abstract] [Full Text] [Related]
5. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole. Ahearn DG, McGlohn MS. J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491 [Abstract] [Full Text] [Related]
6. [Sensitivity of Candida to 5-fluorocytosine and amphotericin B]. Pawlik B, Budak A, Macura A, Laskownicka Z. Med Dosw Mikrobiol; 1978 Mar; 30(1):43-8. PubMed ID: 692181 [No Abstract] [Full Text] [Related]
7. [Synergistic action of amphotericin B and 5-fluorocytosine on Fonsecaea pedrosoi]. de Resende MA. Rev Inst Med Trop Sao Paulo; 1979 Mar; 21(6):344-6. PubMed ID: 550288 [No Abstract] [Full Text] [Related]
16. In vitro studies of amphotericin B in combination with the imidazole antifungal compounds clotrimazole and miconazole. Cosgrove RF, Beezer AE, Miles RJ. J Infect Dis; 1978 Nov; 138(5):681-5. PubMed ID: 361901 [Abstract] [Full Text] [Related]